CDTNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as CDTTW
CDT Equity Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.19−0.05 (-20.88%)
Close on Oct 19, 2026
- Market cap
- $99.14K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$22,124.8140 (−100.00%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $99.14K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.00
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Net income
- -$37.15M
- EPS, diluted
- -$1177.89
- Book value per share
- $193.42
- Diluted shares
- 1M
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Operating income
-$34.85M
Net income
-$37.15M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months